HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M D Caballero Selected Research

BEAM regimen

10/2004Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study.
3/2004Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M D Caballero Research Topics

Disease

5Hodgkin Disease (Hodgkin's Disease)
01/2019 - 03/2001
4Neoplasms (Cancer)
07/2016 - 03/2001
4Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2010 - 02/2001
4Lymphoma (Lymphomas)
04/2007 - 02/2001
4Graft vs Host Disease (Graft-Versus-Host Disease)
02/2005 - 10/2001
3Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
12/2008 - 12/2003
3Multiple Myeloma
10/2001 - 08/2000
2Thrombocytopenia (Thrombopenia)
01/2019 - 05/2004
2B-Cell Lymphoma (Lymphoma, B Cell)
12/2008 - 12/2003
2Non-Hodgkin Lymphoma (Lymphosarcoma)
10/2004 - 02/2001
2Infections
10/2001 - 08/2001
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
07/2016
1Ischemic Stroke
07/2011
1T-Cell Lymphoma (Lymphoma, T Cell)
12/2006
1Second Primary Neoplasms (Neoplasms, Second)
03/2001
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2001
1Plasma Cell Leukemia
01/2001
1Paraproteinemias (Monoclonal Gammopathy)
01/2001
1Smoldering Multiple Myeloma
01/2001
1Hemorrhagic Cystitis
12/2000
1Leukemia
11/2000
1Splenic Rupture
11/2000
1Pathologic Complete Response
08/2000

Drug/Important Bio-Agent (IBA)

514-thioglycolamido-7,8-dihydromorphinone (TAMO)IBA
04/2005 - 02/2001
2Etoposide (VP 16)FDA LinkGeneric
10/2004 - 03/2004
1Brentuximab VedotinIBA
01/2019
1eltrombopagFDA Link
01/2019
1fludarabineIBA
07/2016
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
07/2011
1Rituximab (Mabthera)FDA Link
09/2010
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
04/2007
1AntigensIBA
05/2004
1Human Platelet AntigensIBA
05/2004
1Cyclosporine (Ciclosporin)FDA LinkGeneric
12/2001
1Methotrexate (Mexate)FDA LinkGeneric
12/2001
1Fluconazole (Zonal)FDA LinkGeneric
10/2001
1Cyclin-Dependent Kinase Inhibitor p16IBA
01/2001
1SodiumIBA
01/2001
1EnzymesIBA
01/2001
1Vidarabine (Vira-A)FDA Link
12/2000
1Hemoglobins (Hemoglobin)IBA
11/2000
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
08/2000

Therapy/Procedure

14Stem Cell Transplantation
01/2019 - 12/2000
7Drug Therapy (Chemotherapy)
09/2010 - 02/2001
5Transplantation
05/2004 - 08/2000
4Therapeutics
01/2019 - 12/2000
4Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
10/2001 - 08/2000
2Autologous Transplantation
04/2007 - 10/2004
2Homologous Transplantation
12/2006 - 02/2005
2Time-to-Treatment
04/2005 - 03/2001
2BEAM regimen
10/2004 - 03/2004
2Salvage Therapy
12/2003 - 04/2001
2Blood Component Removal (Apheresis)
10/2001 - 08/2000
1MDC protocol
07/2016
1Cell Transplantation
07/2016
1Induction Chemotherapy
10/2004
1Blood Transfusion (Blood Transfusions)
05/2004
1Adjuvant Radiotherapy
03/2001